Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proceedings of PRINCETON IV: PDE5 inhibitors and cardiac health symposium.
Rosen RC, Miner M, Burnett AL, Blaha MJ, Ganz P, Goldstein I, Kim N, Kohler T, Lue T, McVary K, Mulhall J, Parish SJ, Sadeghi-Nejad H, Sadovsky R, Sharlip I, Kloner RA. Rosen RC, et al. Among authors: goldstein i. Sex Med Rev. 2024 Sep 25;12(4):681-709. doi: 10.1093/sxmrev/qeae043. Sex Med Rev. 2024. PMID: 38936840 Review.
Effects of Flibanserin on Subdomain Scores of the Female Sexual Function Index in Women With Hypoactive Sexual Desire Disorder.
Simon JA, Clayton AH, Goldstein I, Kingsberg SA, Shapiro M, Patel S, Kim NN. Simon JA, et al. Among authors: goldstein i. Sex Med. 2022 Dec;10(6):100570. doi: 10.1016/j.esxm.2022.100570. Epub 2022 Nov 10. Sex Med. 2022. PMID: 36400683 Free PMC article.
CONCLUSION: These analyses suggest that assessment of benefit of flibanserin in HSDD should include improvements across all domains of sexual function, not only desire. Simon JA, Clayton AH, Goldstein I, et al. Effects of Flibanserin on Subdomain Scores of the Femal …
CONCLUSION: These analyses suggest that assessment of benefit of flibanserin in HSDD should include improvements across all domains of sexua …
Response to Commentary by Spielmans.
Simon JA, Clayton AH, Goldstein I, Kingsberg SA, Shapiro M, Patel S, Kim NN. Simon JA, et al. Among authors: goldstein i. Sex Med. 2022 Dec;10(6):100585. doi: 10.1016/j.esxm.2022.100585. Sex Med. 2022. PMID: 36529480 Free PMC article. No abstract available.
Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health.
Kloner RA, Burnett AL, Miner M, Blaha MJ, Ganz P, Goldstein I, Kim NN, Kohler T, Lue T, McVary KT, Mulhall JP, Parish SJ, Sadeghi-Nejad H, Sadovsky R, Sharlip ID, Rosen RC. Kloner RA, et al. Among authors: goldstein i. J Sex Med. 2024 Jan 30;21(2):90-116. doi: 10.1093/jsxmed/qdad163. J Sex Med. 2024. PMID: 38148297
[No title available]
[No authors listed] [No authors listed] PMID: 39216874
1,401 results